171 related articles for article (PubMed ID: 37349822)
1. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
4. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.
Yeh PT; Kennedy CE; de Vuyst H; Narasimhan M
BMJ Glob Health; 2019; 4(3):e001351. PubMed ID: 31179035
[TBL] [Abstract][Full Text] [Related]
5. Interventions to increase the uptake of cervical cancer screening in low- and middle-income countries: a systematic review and meta-analysis.
Tin KN; Ngamjarus C; Rattanakanokchai S; Sothornwit J; Aue-Aungkul A; Paing AK; Pattanittum P; Jampathong N; Lumbiganon P
BMC Womens Health; 2023 Mar; 23(1):120. PubMed ID: 36959632
[TBL] [Abstract][Full Text] [Related]
6. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
7. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
8. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
Di Gennaro G; Licata F; Trovato A; Bianco A
Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
[TBL] [Abstract][Full Text] [Related]
9. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
10. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
[TBL] [Abstract][Full Text] [Related]
11. Human Papilloma Virus self-sampling performance in low- and middle-income countries.
Kamath Mulki A; Withers M
BMC Womens Health; 2021 Jan; 21(1):12. PubMed ID: 33407355
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.
Tesfahunei HA; Ghebreyesus MS; Assefa DG; Zeleke ED; Acam J; Joseph M; Getachew E; Kajogoo VD; Bekele D; Manyazewal T
Infect Agent Cancer; 2021 Jun; 16(1):43. PubMed ID: 34147103
[TBL] [Abstract][Full Text] [Related]
13. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
[TBL] [Abstract][Full Text] [Related]
14. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
Okeah BO; Ridyard CH
Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
17. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
18. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
Sy F; Greuel M; Winkler V; Bussmann H; Bärnighausen T; Deckert A
Gynecol Oncol; 2022 Aug; 166(2):358-368. PubMed ID: 35781165
[TBL] [Abstract][Full Text] [Related]
20. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
